Metabolic HealthResearch PaperPaywall

Continuous Ketone Sensors Reveal Frequent Benign Ketosis in Type 1 Diabetes on Low-Carb Diets

New sensor data shows type 1 diabetics on ketogenic diets experience frequent, short-lived, asymptomatic ketosis episodes — mostly harmless.

Thursday, July 2, 2026 1 view
Published in Diabetes Technol Ther
A person wearing a small wearable sensor patch on their arm, seated at a table with a low-carb meal of eggs, avocado, and leafy greens, with a glucose monitor and ketone meter nearby

Summary

A McGill University study used continuous ketone sensors to monitor 16 adults with type 1 diabetes during ketogenic diets. Participants experienced about 3.7 ketosis episodes per week, each lasting roughly an hour, but nearly all were asymptomatic and resolved on their own. The SiBio continuous ketone sensor showed reasonable accuracy compared to finger-stick measurements. Importantly, blood glucose levels and insulin delivery did not predict when these ketosis events occurred. The findings suggest that brief, benign ketosis is a normal physiological response to very-low-carbohydrate eating in type 1 diabetes — and that continuous ketone monitoring could help clinicians distinguish dangerous diabetic ketoacidosis from harmless dietary ketosis.

Detailed Summary

Diabetic ketoacidosis (DKA) is one of the most feared complications of type 1 diabetes, yet not all elevated ketone levels signal danger. As ketogenic and very-low-carbohydrate diets grow in popularity among people managing type 1 diabetes, clinicians need better tools to distinguish harmful DKA from benign dietary ketosis. Continuous ketone sensors may be that tool — but their real-world accuracy and the true frequency of ketosis events have not been well characterized until now.

Researchers at McGill University enrolled 16 adults with type 1 diabetes on automated insulin delivery systems. Participants wore SiBio continuous ketone sensors and followed two 6-day dietary protocols in random order: a very-low-carbohydrate diet (under 50g carbs/day) and a 12-hour intermittent fasting regimen. Sensor accuracy was validated against capillary ketone measurements using the FreeStyle Libre 2 meter across 870 paired data points.

The sensor performed acceptably, with a mean absolute difference of 0.1 mmol/L at low ketone levels and relative errors of roughly 20–24% at clinically significant thresholds. During the combined 155 days of dietary monitoring, participants experienced 81 distinct ketosis events at or above 0.6 mmol/L, averaging 3.7 events per week. Median event duration was 60 minutes. Critically, all but one event were entirely asymptomatic, and neither glucose levels nor insulin delivery predicted their occurrence.

These findings have real implications for diabetes management. Clinicians and patients using ketogenic diets need not panic at every ketone elevation — transient, asymptomatic ketosis appears to be a routine physiological response. Continuous ketone sensors could eventually help automate DKA prevention while reducing unnecessary alarm.

Caveats include the small sample size of 16 participants, the controlled study setting, and the fact that this summary is based on the abstract only. Sensor accuracy at higher ketone ranges warrants further validation before widespread clinical deployment.

Key Findings

  • Type 1 diabetics on ketogenic diets averaged 3.7 asymptomatic ketosis episodes per week, each lasting ~60 minutes.
  • Nearly all ketosis events were benign and self-resolving — only 1 of 81 events was symptomatic.
  • Blood glucose and insulin delivery did not predict when ketosis episodes occurred.
  • The SiBio continuous ketone sensor showed ~20% relative error at clinically significant ketone levels ≥0.6 mmol/L.
  • Continuous ketone monitoring may help clinicians distinguish dietary ketosis from dangerous DKA in real time.

Methodology

Sixteen adults with type 1 diabetes on automated insulin delivery completed two randomized 6-day ketogenic dietary protocols: very-low-carbohydrate (<50g/day) and 12-hour intermittent fasting. Continuous ketone sensor readings were validated against capillary measurements across 870 paired data points. An in-clinic insulin suspension experiment was used as an additional accuracy benchmark.

Study Limitations

The study enrolled only 16 participants, limiting statistical power and generalizability. Sensor accuracy at higher ketone concentrations remains uncertain and requires larger validation studies. This summary is based on the abstract only, as the full text was not available.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: